Sustained monitoring by the WHO shows no new COVID variants of concern emerging through late 2026, with dominant Omicron descendants like JN.1 sublineages and strains such as XFG, NB.1.8.1, and BA.3.2 remaining classified only as variants under monitoring due to limited evidence of heightened severity or rapid dominance. Recent detections in regions including India and Europe have prompted continued genomic surveillance and vaccine updates targeting prevalent lineages for the 2026-2027 season, yet risk assessments indicate low global impact and no escalation to variants of interest or concern. This pattern of gradual evolution within established families underpins trader consensus favoring no new designation of concern before 2027, though an unexpected mutation conferring significant immune escape or transmissibility advantages could still shift probabilities.